Showing results (391-400 of 564) with videos related to
Sort By:
Pageof 57
The Journal of Supportive Oncology|June 18, 2010
Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CBAmanda R Moraska, Pamela J Atherton, Daniel W Szydlo, et al.Chemical Senses|April 27, 2010
Mouse urinary biomarkers provide signatures of maturation, diet, stress level, and diurnal rhythmMichele L Schaefer, Kanet Wongravee, Maria E Holmboe, et al.BMJ Open Quality|April 8, 2024
Call me Ishmael: addressing the white whale of team communication in the operating room with labelled surgical caps at an academic medical centreNicole Hamilton Goldhaber, Shivani Mehta, Christopher A Longhurst, et al.Neuro-Oncology|June 27, 2002
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomasHiroko Kuriyama, Kathleen R Lamborn, Judith R O'Fallon, et al.American Journal of Clinical Oncology|June 11, 2003
Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancersPaul L Schaefer, Randolph S Marks, Michelle R Mahoney, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2010
Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB)Aminah Jatoi, Shaker R Dakhil, Jeff A Sloan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancerT R Buroker, M J O'Connell, H S Wieand, et al.Lung Cancer (Amsterdam, Netherlands)|March 16, 2000
A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancerJ J Weitz, R F Marschke, J A Sloan, et al.American Journal of Clinical Oncology|October 22, 1998
A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinomaE T Creagan, M H Veeder, V J Suman, et al.Nature|June 20, 2008
A new class of homoserine lactone quorum-sensing signalsAmy L Schaefer, E P Greenberg, Colin M Oliver, et al.Pageof 57